LK-2

General Information


DRACP ID  DRACP05587

Peptide Name   LK-2

Sequence  LKKLCKLLKKLCKLAG

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C83H158N22O17S2

Absent amino acids  DEFHIMNPQRSTVWY

Common amino acids  KL

Mass  206819

Pl  10.8

Basic residues  6

Acidic residues  0

Hydrophobic residues  7

Net charge  6

Boman Index  153

Hydrophobicity  36.25

Aliphatic Index  152.5

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  8.33

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25056130

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2434

DRACP is developed by Dr.Zheng's team.